Foreword: Meeting the challenge of prostate cancer

A Auvinen; Harry de Koning; Jan Willem Coebergh

doi:10.1016/j.ejca.2010.09.037

Foreword: Meeting the challenge of prostate cancer

A Auvinen
, Harry de Koning
, Jan Willem Coebergh

Public Health

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Abstract

Prostate cancer is a key medical and public health challenge. Though it is currently the most common cancer among men in Europe, its natural history, prognosis and treatment are poorly understood in comparison to breast cancer. Prostate cancers diagnosed are very small and prediction of their progression at the individual level is difficult and hence need for aggressive management is unclear. The number of randomised treatment trials remains shamefully small and hence the relative effectiveness of the new treatment modalities introduced is unclear. (C) 2010 Published by Elsevier Ltd.

Original language	Undefined/Unknown
Pages (from-to)	3037-3039
Number of pages	3
Journal	European Journal of Cancer
Volume	46
Issue number	17
DOIs	https://doi.org/10.1016/j.ejca.2010.09.037
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC NIHES-02-65-01

Access to Document

10.1016/j.ejca.2010.09.037

http://hdl.handle.net/1765/21381

Cite this

@article{6d5eeb8e4cca4682b9e1882ba0e9f33a,

title = "Foreword: Meeting the challenge of prostate cancer",

abstract = "Prostate cancer is a key medical and public health challenge. Though it is currently the most common cancer among men in Europe, its natural history, prognosis and treatment are poorly understood in comparison to breast cancer. Prostate cancers diagnosed are very small and prediction of their progression at the individual level is difficult and hence need for aggressive management is unclear. The number of randomised treatment trials remains shamefully small and hence the relative effectiveness of the new treatment modalities introduced is unclear. (C) 2010 Published by Elsevier Ltd.",

author = "A Auvinen and \{de Koning\}, Harry and Coebergh, \{Jan Willem\}",

year = "2010",

doi = "10.1016/j.ejca.2010.09.037",

language = "Undefined/Unknown",

volume = "46",

pages = "3037--3039",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "17",

}

TY - JOUR

T1 - Foreword: Meeting the challenge of prostate cancer

AU - Auvinen, A

AU - de Koning, Harry

AU - Coebergh, Jan Willem

PY - 2010

Y1 - 2010

N2 - Prostate cancer is a key medical and public health challenge. Though it is currently the most common cancer among men in Europe, its natural history, prognosis and treatment are poorly understood in comparison to breast cancer. Prostate cancers diagnosed are very small and prediction of their progression at the individual level is difficult and hence need for aggressive management is unclear. The number of randomised treatment trials remains shamefully small and hence the relative effectiveness of the new treatment modalities introduced is unclear. (C) 2010 Published by Elsevier Ltd.

AB - Prostate cancer is a key medical and public health challenge. Though it is currently the most common cancer among men in Europe, its natural history, prognosis and treatment are poorly understood in comparison to breast cancer. Prostate cancers diagnosed are very small and prediction of their progression at the individual level is difficult and hence need for aggressive management is unclear. The number of randomised treatment trials remains shamefully small and hence the relative effectiveness of the new treatment modalities introduced is unclear. (C) 2010 Published by Elsevier Ltd.

U2 - 10.1016/j.ejca.2010.09.037

DO - 10.1016/j.ejca.2010.09.037

M3 - Article

C2 - 21047584

SN - 0959-8049

VL - 46

SP - 3037

EP - 3039

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 17

ER -